These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6282541)

  • 1. A model for service delivery research and evaluation: management implications for alcohol, drug abuse and mental health organizations.
    Gregory D; Rundell OH
    Curr Alcohol; 1981; 8():119-36. PubMed ID: 6282541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Grant award to the Division of Mental Health and Developmental Disabilities, Department of Health and Social Services, State of Alaska. Center for Substance Abuse Treatment (CSAT), Center for Mental Health Services (CMHS), Substance Abuse and Mental Health Services Administration (SAMHSA), HHS. Availability of grant funds for the Division of Mental Health and Developmental Disabilities, Department of Health and Social Services, State of Alaska.
    Fed Regist; 1999 Apr; 64(73):18922-3. PubMed ID: 10558551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An accountability model for integrating information systems, evaluation mechanisms, and decision making processes in alcohol and drug abuse agencies.
    Duncan FH; Link AD
    Addict Dis; 1979; 3(4):517-31. PubMed ID: 233539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Public substance abuse and managed behavioral healthcare. American Managed Behavioral Healthcare Association and National Association of State Alcohol and Drug Abuse Directors, Inc.
    Behav Healthc Tomorrow; 1999 Feb; 8(1):25-30. PubMed ID: 10346117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in outpatient mental health service utilization under capitation.
    Chou AF; Wallace N; Bloom JR; Hu TW
    J Ment Health Policy Econ; 2005 Mar; 8(1):3-14. PubMed ID: 15870481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcohol, Drug Abuse, and Mental Health Administration; statement of organization, functions, and delegations of authority--PHS.
    Fed Regist; 1986 May; 51(91):17414-5. PubMed ID: 10314177
    [No Abstract]   [Full Text] [Related]  

  • 8. The National Alcohol Research Centers Program.
    Pawlowski A
    Alcohol Health Res World; 1988; 12(4):262-7. PubMed ID: 10314323
    [No Abstract]   [Full Text] [Related]  

  • 9. Monitoring and evaluation at NIAAA.
    Chafetz ME
    Evaluation; 1974; 2(1):49-52. PubMed ID: 10313888
    [No Abstract]   [Full Text] [Related]  

  • 10. Linking research and service delivery: the unique mission of the Substance Abuse and Mental Health Services Administration.
    Jansen MA
    NIDA Res Monogr; 1994; 140():23-6. PubMed ID: 8722449
    [No Abstract]   [Full Text] [Related]  

  • 11. Privacy Act of 1974; altered system of records--PHS. Notification of altered system of records: 09-30-0036, "Alcohol, Drug Abuse, and Mental Health Epidemiologic and Biometric Research Data, HHS/ADAMHA/OA".
    Fed Regist; 1984 Oct; 49(206):42639-42. PubMed ID: 10314092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New directions in alcohol and drug treatment under managed care.
    Weisner C; McCarty D; Schmidt L
    Am J Manag Care; 1999 Jun; 5 Spec No():SP57-69. PubMed ID: 10538861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The design of Healthcare for Communities: a study of health care delivery for alcohol, drug abuse, and mental health conditions.
    Sturm R; Gresenz C; Sherbourne C; Minnium K; Klap R; Bhattacharya J; Farley D; Young AS; Burnam MA; Wells KB
    Inquiry; 1999; 36(2):221-33. PubMed ID: 10459376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dealing with alcohol and drug abuse and mental illness.
    Klerman GL
    Public Health Rep; 1978; 93(6):622-6. PubMed ID: 213804
    [No Abstract]   [Full Text] [Related]  

  • 16. Biomedicalization and alcohol studies: implications for policy.
    Midanik LT
    J Public Health Policy; 2004; 25(2):211-28. PubMed ID: 15255386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ryan White CARE Act Title IV programs: a preliminary characterization of benefits and costs.
    Abramowitz S; Greene D
    AIDS Public Policy J; 2005; 20(3-4):108-25. PubMed ID: 17624034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Privacy Act; notification of a new system of records. Public Health Service. Notification of a new system of records: 09-30-0039, "Drug Abuse Treatment Outcome Prospective Study (TOPS)".
    Fed Regist; 1982 Jan; 47(11):2508-10. PubMed ID: 10317167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.